Generate a tailored SOP for Dr. Nicholas Huntington. Improve your application with a focused, well-structured draft.
Nicholas Huntington heads the Cancer Immunotherapy Laboratory at the Biomedicine Discovery Institute, Monash University, Australia. He is an international leader in natural killer (NK) cell biology, having made notable contributions to understanding the regulatory mechanisms of IL-15 signaling in NK cells and identifying human and murine NK cell differentiation pathways. His research utilizes novel xenograft models to study human hematopoiesis, focusing on multiple checkpoints of NK cell activation and tumor immunity. Huntington leads research programs aimed at deciphering the regulatory networks that control NK cell immunity and has developed drug discovery programs using cutting-edge in vivo screens to identify novel checkpoints for NK cell activation targeting cancer immunotherapy. He is also the President of the Melbourne Immunotherapy Network, serving as project director for collaborative research programs with the Walter Eliza Hall Institute, and co-founder and chief scientific officer of oNKo-Innate Pty Ltd.
Walter Eliza Hall Institute of Medical Research (WEHI) • Melbourne, VIC, Australia
Led a laboratory focused on cancer immunotherapy.
University of Melbourne • Melbourne, VIC, Australia
Conducted research in the Department of Immunology.
Walter Eliza Hall Institute of Medical Research (WEHI) • Melbourne, VIC, Australia
Led research into NK cell functions.
Institut Pasteur • Paris, France
Conducted advanced research in immunology.
Institut Pasteur • Paris, France
Supported research in immune cell functions.
Walter Eliza Hall Institute of Medical Research (WEHI) • Melbourne, VIC, Australia
Focused on cancer research as a postdoctoral fellow.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.